Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-01-28
1994-12-20
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, A61K 3702
Patent
active
053746228
ABSTRACT:
A fibrinogen receptor antagonist of the formula
REFERENCES:
patent: 4559324 (1985-12-01), Fujino
patent: 4772686 (1988-09-01), Szelke
patent: 4857508 (1989-08-01), Adams
patent: 4952562 (1990-08-01), Klein
patent: 4988621 (1991-01-01), Ruoslahti
Ramjit J Pharm Exp Ther 266, 1501, 1993.
Plow, Proc Natl Acad Sci 82, 8057, 1985.
Rose, Adv Prot Chem 37, 19-45, 1985.
Smith J Med Chem 21, 117, 1978.
Pierschbacher Proc Natl Acad Sci 81, 5985-5988, 1984.
Nutt, Peptides, Struct and Funct 441-444, 1985.
Hase J Am Chem Soc 94, 3590, 1972.
Progress in Drugs Research (1966) pp. 508-509, Ariens et al.
J. Biol. Chem. (1987), 262 (86) pp. 17294-17298 (A) Influence of Stereochemistry, Pierschbacher et al.
Brady Stephen F.
Duggan Mark E.
Nutt Ruth F.
Veber Daniel F.
Hill Jr. Robert J.
Lukton David
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2386280